McCarthy Tétrault receives four Benchmark Canada awards
McCarthy Tétrault is delighted to announce that Euromoney Legal Media Group’s Benchmark Canada named partners Andrew Reddon and Steven Mason as Canada’s Intellectual Property Litigators of the Year – Patents. The award is in recognition of Mr. Reddon and Mr. Mason’s exceptional knowledge of patents and superior trial skills. The pair’s recent successes include their representation of AbbVie in its patent infringement case against Janssen related to AbbVie’s Canadian patent on anti-IL-12 antibodies. This was Canada’s first antibody engineering trial, and the action was the first in Canada dealing with the scope of protection for the new class of drugs known as "biologics". Mr. Reddon and Mr. Mason also recently successfully assisted Merck in recovering more than C$180 million in damages and interest for Apotex’s infringement of Merck’s Canadian lovastatin patent – possibly the largest patent damages award in Canada to date.
Benchmark Canada also honoured McCarthy Tétrault with three National Impact Case awards:
- for our successful representation of former Nortel CEO Frank Dunn in Regina v. Dunn, Beatty and Gollogly
- for having successfully assisted Merck in Merck & Co. Inc. and Merck Canada Inc. v. Apotex Inc. et al.
- for having successfully assisted TD Bank as an intervenor in The Commissioner of Competition v. Visa Canada Corporation and MasterCard International Incorporated
Benchmark Canada applies research, peer reviews and interviews with litigators and theirs clients to identify award-winning litigators and firms. Read more about the awards here.
AbbVie anti-IL-12 antibody antibody engineering award Benchmark Canada biologic Janssen lovastatin Merck Patent Infringement pharmaceutical patent